Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Brook

Showing results (61-70 of 83) with videos related to

Pageof 9
Sort By:
Sexually Transmitted Infections|April 12, 2003
Treating sexually transmitted infections in primary care: a missed opportunity?J A Cassell, M G Brook, C H Mercer, et al.
International Journal of STD & AIDS|March 1, 2007
Management of rape/sexual assault cases within genitourinary medicine clinics: results from a study in North ThamesS Obeyesekera, K Jones, G E Forster, et al.
Sexually Transmitted Infections|February 11, 2003
Maintaining patient access to GUM clinics: is it compatible with appointments?J A Cassell, M G Brook, C H Mercer, et al.
Sexually Transmitted Infections|June 10, 2003
Partner notification in primary careJ A Cassell, M G Brook, R Slack, et al.
Lancet (London, England)|January 7, 1989
Anti-HIV effects of alpha-interferonM G Brook, D Gor, S Forster, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1993
Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infectionM G Brook, J Main, I Yap, et al.
International Journal of STD & AIDS|March 7, 2001
Management of Chlamydia trachomatis genital tract infection in Genitourinary Medicine clinics in the United Kingdom's North Thames Region 1999A W Dale, P J Horner, G E Forster, et al.
AIDS (London, England)|October 1, 1988
Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis BM G Brook, D Gor, S M Forster, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomasM G Brook, A A Dunk, J A McDonald, et al.
BMJ (Clinical Research Ed.)|December 8, 1990
Toxic dilatation of the colon in shigellosisA P Wilson, G L Ridgway, M Sarner, et al.
Pageof 9

Showing results (61-70 of 83) with videos related to

Sort By:
Pageof 9
Sexually Transmitted Infections|April 12, 2003
Treating sexually transmitted infections in primary care: a missed opportunity?J A Cassell, M G Brook, C H Mercer, et al.
International Journal of STD & AIDS|March 1, 2007
Management of rape/sexual assault cases within genitourinary medicine clinics: results from a study in North ThamesS Obeyesekera, K Jones, G E Forster, et al.
Sexually Transmitted Infections|February 11, 2003
Maintaining patient access to GUM clinics: is it compatible with appointments?J A Cassell, M G Brook, C H Mercer, et al.
Sexually Transmitted Infections|June 10, 2003
Partner notification in primary careJ A Cassell, M G Brook, R Slack, et al.
Lancet (London, England)|January 7, 1989
Anti-HIV effects of alpha-interferonM G Brook, D Gor, S Forster, et al.
Alimentary Pharmacology & Therapeutics|June 1, 1993
Short report: prednisolone withdrawal followed by lymphoblastoid interferon in the therapy of adult patients with presumed childhood-acquired chronic hepatitis B virus infectionM G Brook, J Main, I Yap, et al.
International Journal of STD & AIDS|March 7, 2001
Management of Chlamydia trachomatis genital tract infection in Genitourinary Medicine clinics in the United Kingdom's North Thames Region 1999A W Dale, P J Horner, G E Forster, et al.
AIDS (London, England)|October 1, 1988
Suppression of HIV p24 antigen and induction of HIV anti-p24 antibody by alpha interferon in patients with chronic hepatitis BM G Brook, D Gor, S M Forster, et al.
Alimentary Pharmacology & Therapeutics|August 1, 1987
Human lymphoblastoid interferon does not increase survival when added to mitozantrone in the treatment of hepatocellular carcinomasM G Brook, A A Dunk, J A McDonald, et al.
BMJ (Clinical Research Ed.)|December 8, 1990
Toxic dilatation of the colon in shigellosisA P Wilson, G L Ridgway, M Sarner, et al.
Pageof 9